AIM
KZR

Alambic Investment Management’s Kezar Life Sciences KZR Stock Holding History

Alambic Investment Management’s Portfolio KZR Stock Details KZR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-2,114
Closed -$102K – 28
2020
Q3 		$102K Sell
2,114
-48
-2% -$2.3K 1.12% 31
2020
Q2 		$112K Sell
2,162
-10
-0.5% -$505 0.28% 128
2020
Q1 		$95K Sell
2,172
-520
-19% -$21.2K 0.23% 135
2019
Q4 		$108K Sell
2,692
-3,669
-58% -$113K 0.09% 241
2019
Q3 		$209K Buy
+6,361
New +$307K 0.16% 208

Other funds holding KZR

BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return
CS
Candriam SCA Strassen, Luxembourg, Luxembourg $22.2B AUM 58.34% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return

Alambic Investment Management's KZR Position: Q4 2020 in Review

Alambic Investment Management sold out of Kezar Life Sciences (KZR) in Q4 2020, closing a stake of 2,114 shares — an estimated $102K sold.

Alambic Investment Management first reported a position in KZR in Q3 2019 and held it in 5 quarters. The position peaked at $209K in Q3 2019. 77 funds tracked by Wall St. Rank hold KZR as of Q4 2020.

  • Alambic Investment Management reported no remaining Kezar Life Sciences position as of Q4 2020 after selling out during the quarter.
  • Alambic Investment Management sold 2,114 Kezar Life Sciences shares in Q4 2020, an estimated $102K.
  • Alambic Investment Management first reported a position in Kezar Life Sciences in Q3 2019 and held it in 5 quarters.
  • Alambic Investment Management's Kezar Life Sciences position peaked at $209K in Q3 2019.
  • 77 funds tracked by Wall St. Rank held Kezar Life Sciences as of Q4 2020.

Based on Alambic Investment Management's 13F filing for Q4 2020.